Get the Stockscreener App
1.95
1.52%
-0.03
After Hours:
1.90
-0.05
-2.56%
Icad Inc stock is traded at $1.95, with a volume of 277.97K.
It is down -1.52% in the last 24 hours and down -19.09% over the past month.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
See More
Previous Close:
$1.98
Open:
$1.92
24h Volume:
277.97K
Relative Volume:
0.63
Market Cap:
$52.18M
Revenue:
$18.94M
Net Income/Loss:
$-2.71M
P/E Ratio:
-13.93
EPS:
-0.14
Net Cash Flow:
$-4.92M
1W Performance:
-11.36%
1M Performance:
-19.09%
6M Performance:
+21.12%
1Y Performance:
+21.87%
1-Day Range:
$1.90
$2.00
1-Week Range:
$1.90
$2.21
52-Week Range:
$1.18
$3.78
Icad Inc Stock (ICAD) Company Profile
Name
Icad Inc
Sector
Industry
Phone
603-882-5200
Address
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
Compare ICAD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICAD
Icad Inc
|
1.95 | 52.18M | 18.94M | -2.71M | -4.92M | -0.14 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-18-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-22-21 | Initiated | Guggenheim | Buy |
| Mar-23-21 | Initiated | BTIG Research | Buy |
| Feb-26-21 | Initiated | Oppenheimer | Outperform |
| Jan-29-21 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-03-20 | Initiated | B. Riley Securities | Buy |
| Feb-05-20 | Initiated | JMP Securities | Mkt Outperform |
| Jan-09-20 | Initiated | Lake Street | Buy |
| Dec-09-08 | Reiterated | Canaccord Adams | Buy |
| Aug-01-08 | Reiterated | MDB Capital Group | Buy |
| May-14-08 | Reiterated | Canaccord Adams | Buy |
| Feb-14-08 | Initiated | Sun Trust Rbsn Humphrey | Buy |
| Jan-24-07 | Reiterated | Dawson James | Speculative Buy |
View All
Icad Inc Stock (ICAD) Latest News
iCAD and RamSoft partner to enhance breast cancer detection with AI - Outsource Accelerator
ICAD targets SaaS growth with ProFound Cloud expansion and AI advancements - MSN
iCAD Inc. Earnings Call Highlights Growth and Challenges - TipRanks
iCAD, RamSoft to Deliver ProFound AI-Powered Mammography Solutions - Medical Product Outsourcing
iCAD, Inc. (NASDAQ:ICAD) Q4 2024 Earnings Call Transcript - Insider Monkey
iCAD (NASDAQ:ICAD) Issues Earnings Results - MarketBeat
iCAD, Inc. (NASDAQ:ICAD): Is Breakeven Near? - Yahoo Finance
iCAD Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
BTIG maintains Buy rating and $3 target on iCAD shares - Investing.com
BTIG maintains Buy rating and $3 target on iCAD shares By Investing.com - Investing.com UK
icad Inc (ICAD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic SaaS ... - Yahoo Finance
icad Inc (ICAD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic SaaS Transition - GuruFocus.com
iCAD, Inc. Reports Strong Revenue Growth Amid SaaS Transition - TipRanks
Icad: Q4 Earnings Snapshot - mySA
Earnings call transcript: iCAD Q4 2024 beats EPS forecast, stock surges - Investing.com Australia
ICAD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
icad Inc (ICAD) Q4 2024 Earnings: EPS Loss of ($0.03) Beats Esti - GuruFocus
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024 - TradingView
iCAD (ICAD) to Release Earnings on Wednesday - Defense World
iCAD (NASDAQ:ICAD) Shares Pass Above 200 Day Moving Average – Time to Sell? - Defense World
Advancing AI-Powered Breast Health Solutions to Transform Global Healthcare | Newswise - Newswise
iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025 - The Manila Times
Key Earnings Date: AI Cancer Detection Leader iCAD Sets Q4 2024 Results Release - StockTitan
iCAD, Inc. to Host Earnings Call - ACCESS Newswire
iCAD (ICAD) Expected to Announce Earnings on Monday - Defense World
iCAD, RamSoft Integrate to Enhance AI Breast Cancer Detection - HIT Consultant
ICAD, RamSoft Collaborate to Enhance Breast Cancer Detection -March 05, 2025 at 03:20 pm EST - Marketscreener.com
iCAD, Inc. and RamSoft® Announce Strategic Integration Partnership to Enhance AI-Powered Breast Health Solutions Across North America - Nasdaq
iCAD and RamSoft Announce Partnership to Deliver ProFound® - GlobeNewswire
Can This AI Technology Catch the 40% of Breast Cancers That Mammograms Miss? - StockTitan
Investor Network: iCAD, Inc. to Host Earnings Call - ACCESS Newswire
iCAD, Inc. (ICAD) and Koios Partner to Enhance AI-Powered Breast Cancer Detection - Insider Monkey
iCAD, Inc. and Koios Medical Announce Strategic Partnership for AI-Powered Breast Cancer Detection Solutions - Nasdaq
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025 - GlobeNewswire
Can This New AI Partnership Transform Breast Cancer Detection? iCAD Teams With Koios - Stock Titan
Artificial Intelligence (AI) in Breast Imaging Market to - GlobeNewswire
iCAD, Inc. (ICAD): A Bull Case Theory - Insider Monkey
iCAD, Inc. (ICAD) to Showcase AI-Powered Breast Health Innovations at ECR 2025 - Insider Monkey
9 AI News and Ratings on Wall Street’s Radar - Insider Monkey
iCAD To Showcase Five AI-Powered Research Presentations - GlobeNewswire
iCAD Shares Unchanged Ahead of Presentations - Baystreet.ca
Earnings call transcript: ICAD Q4 2024 shows strategic resilience By Investing.com - Investing.com Canada
Can AI Transform Breast Cancer Detection? iCAD's Revolutionary Research Answers Key Questions - StockTitan
iCAD (NASDAQ:ICAD) Shares Pass Above 200 Day Moving AverageWhat's Next? - MarketBeat
Icad Inc Stock (ICAD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):